FFCP PHASE1:Hg19::chr14:88322509..88322516,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr14:88322509..88322516,- | |||
|coexpression_cluster_id=C38 | |||
|description=CAGE_peak_at_chr14:88322509..88322516,- | |||
|id=chr14:88322509..88322516,- | |||
|ontology_enrichment_celltype=CL:0000153!3.75e-21!9;CL:0000447!3.75e-21!9;CL:0000214!1.37e-16!3;CL:0000327!1.04e-13!14;CL:0000540!5.56e-09!6;CL:0000031!5.56e-09!6;CL:0000404!5.56e-09!6;CL:0000667!7.93e-09!6;CL:0000058!7.93e-09!6;CL:0000138!7.93e-09!6;CL:0000499!3.30e-07!27;CL:0000047!6.06e-07!8 | |||
|ontology_enrichment_celltype_v019=CL:0000138;2.19e-12;6!CL:0000540;2.45e-12;6!CL:0000404;2.45e-12;6!CL:0000153;1.04e-08;9!CL:0000447;1.04e-08;9 | |||
|ontology_enrichment_celltype_v019_2=CL:0000058,2.19e-12,6;CL:0000138,2.19e-12,6;CL:0000540,2.45e-12,6;CL:0000031,2.45e-12,6;CL:0000404,2.45e-12,6;CL:0000047,1.35e-09,8;CL:0000153,1.04e-08,9;CL:0000447,1.04e-08,9 | |||
|ontology_enrichment_development_v019=CL:0000031;2.45e-12;6 | |||
|ontology_enrichment_disease=DOID:3371!1.61e-13!1;DOID:4549!1.61e-13!1;DOID:5861!1.61e-13!1;DOID:6496!1.61e-13!1;DOID:4468!4.17e-07!2 | |||
|ontology_enrichment_disease_v019=DOID:3371;1.23e-66;1!DOID:4549;1.23e-66;1!DOID:5861;1.23e-66;1!DOID:6496;1.23e-66;1!DOID:201;2.19e-12;6!DOID:0060100;2.19e-12;6 | |||
|ontology_enrichment_disease_v019_2=DOID:3371,1.23e-66,1;DOID:4549,1.23e-66,1;DOID:5861,1.23e-66,1;DOID:6496,1.23e-66,1;DOID:201,2.19e-12,6;DOID:0060100,2.19e-12,6 | |||
|ontology_enrichment_uberon=UBERON:0006915!1.37e-16!3;UBERON:0002018!1.37e-16!3;UBERON:0002217!1.37e-16!3;UBERON:0007616!1.37e-16!3;UBERON:0004905!2.47e-10!5;UBERON:0000982!2.47e-10!5;UBERON:0004770!2.47e-10!5;UBERON:0001905!2.91e-07!2;UBERON:0002757!2.91e-07!2;UBERON:0010134!2.91e-07!2;UBERON:0002784!2.91e-07!2;UBERON:0005408!2.91e-07!2;UBERON:0001899!2.91e-07!2;UBERON:0001870!5.60e-07!2 | |||
|ontology_enrichment_uberon_v019=UBERON:0002418;2.62e-23;3!UBERON:0004755;2.62e-23;3 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002418,2.62e-23,3;UBERON:0004755,2.62e-23,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.521482918420201,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.144846518960824,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.215627574859517,0,0,0,0.773288812777695,0,2.55175500661265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.127612712494584,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.211107635297664,0.329294892959902,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.210998064528027,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.88326957442601,0,0,0,0.0633107959558787,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.138258436151731,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.20170506870352,0,0,0,0,0,0,0,0,0,0,0,0,0,0.535701835878287,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.1598144313382,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.730336388246517,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.267964130156178,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr14:88322509..88322516,- | |||
}} |
Latest revision as of 23:20, 24 July 2015
Short description: | p@chr14:88322509..88322516, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr14:88322509..88322516, - |
Coexpression cluster: | C38_extraskeletal_rhabdomyosarcoma_adrenal_rectal_mesothelioma_lung_Wilms |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
chondroblast | 2.19e-12 | 6 |
chondrocyte | 2.19e-12 | 6 |
neuron | 2.45e-12 | 6 |
neuroblast | 2.45e-12 | 6 |
electrically signaling cell | 2.45e-12 | 6 |
neuronal stem cell | 1.35e-09 | 8 |
GAG secreting cell | 1.04e-08 | 9 |
carbohydrate secreting cell | 1.04e-08 | 9 |
Ontology term | p-value | n |
---|---|---|
cartilage tissue | 2.62e-23 | 3 |
skeletal tissue | 2.62e-23 | 3 |
Ontology term | p-value | n |
---|---|---|
chondrosarcoma | 1.23e-66 | 1 |
extraosseous chondrosarcoma | 1.23e-66 | 1 |
myxoid chondrosarcoma | 1.23e-66 | 1 |
extraskeletal myxoid chondrosarcoma | 1.23e-66 | 1 |
connective tissue cancer | 2.19e-12 | 6 |
musculoskeletal system cancer | 2.19e-12 | 6 |